Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133469) titled 'Development and validation of a prognostic prediction model for breast cancer based on quantitative assessment of intratumoral heterogeneity using DCE-MRI' on Sept. 28.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Fuzhou University Affiliated Provincial Hospital
Condition:
breast cancer
Intervention:
High ITH score group:none
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-10-01
Target Sample Size: High ITH score group:150;low ITH score group:150;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?...